Terms of Use

1. Acceptance of Terms
By accessing or using the GLP-1 SA Platform at glp1sa.com (“Platform”), you agree to be bound by these Terms of Use (“Terms”). If you do not agree, you must not use the Platform. These Terms are governed by the laws of the Republic of South Africa.

2. About the Platform
GLP-1 SA is a health information and education platform. It provides evidence-based, patient-first information about GLP-1 receptor agonist medications (including semaglutide and tirzepatide) in the South African context.

The Platform is not a medical practice, pharmacy, healthcare provider, or medical aid scheme. It does not provide medical advice, prescriptions, diagnoses, or treatment recommendations. All content is for informational and educational purposes only.

3. Registration and Accounts
Some content on the Platform is available only to registered members. Registration is free. You agree to:
• Provide accurate and truthful information when registering
• Keep your password confidential and not share it with others
• Notify us immediately if you suspect unauthorised use of your account
• Be responsible for all activity that occurs under your account
We reserve the right to suspend or terminate accounts that violate these Terms or that we reasonably suspect of fraudulent or abusive activity.

4. Permitted Use
You may use the Platform for personal, non-commercial informational purposes. You must not:
• Copy, reproduce, or republish Platform content without our written permission
• Use the Platform for commercial purposes without our consent
• Attempt to gain unauthorised access to any part of the Platform or its systems
• Transmit malware, spam, or any harmful or disruptive code
• Scrape, crawl, or extract data from the Platform using automated means
• Impersonate any person or entity or misrepresent your affiliation
• Use the Platform in any way that violates South African law or any applicable regulation

5. Intellectual Property
All content on the Platform — including articles, text, images, graphics, and the Platform design — is owned by or licensed to GLP-1 SA and is protected by South African copyright law and the Copyright Act 98 of 1978.

You may not reproduce, distribute, modify, or create derivative works from Platform content without our express written permission. Links to the Platform are permitted provided they are not framed or misleading.

6. Third-Party Links and Services
The Platform may contain links to third-party websites, including medical journals, news outlets, and regulatory bodies. These links are provided for convenience and do not constitute an endorsement. We have no control over third-party content and are not responsible for it.
The Platform uses Mailchimp for newsletter delivery. Your use of the newsletter subscription feature is subject to Mailchimp’s terms and privacy policy.

7. Disclaimer of Warranties
The Platform and its content are provided “as is” and “as available” without warranties of any kind, express or implied. We do not warrant that:
• The Platform will be available at all times or free from errors
• The content is complete, accurate, or up to date
• The Platform is free from viruses or other harmful components

To the maximum extent permitted by South African law, we disclaim all implied warranties including merchantability, fitness for a particular purpose, and non-infringement.

8. Limitation of Liability
To the maximum extent permitted by the Consumer Protection Act 68 of 2008 and other applicable South African law, GLP-1 SA and its operators shall not be liable for:
• Any direct, indirect, incidental, or consequential loss or damage arising from your use of the Platform
• Any medical decision made in reliance on Platform content
• Any loss of data, revenue, or opportunity arising from Platform unavailability

Nothing in these Terms limits liability for fraud, gross negligence, or any liability that cannot be excluded under South African law.

9. Governing Law and Disputes
These Terms are governed by the laws of the Republic of South Africa. Any dispute arising from these Terms or your use of the Platform shall be subject to the jurisdiction of the South African courts.
Before initiating legal proceedings, we encourage you to contact us to resolve the matter informally.

10. Changes to These Terms
We may revise these Terms from time to time. We will post the updated Terms on the Platform and, for material changes, notify registered users by email. Continued use of the Platform after the effective date of any change constitutes your acceptance of the revised Terms.

11. Contact
For questions about these Terms, contact us at: info@glp1sa.com